CURRICULUM VITAE

Name:RAYMOND D. BAHR, MD, FACP, FACC

Personal:

Addresses:
Residence:
12139 Mt. Albert Road
Ellicott City, Maryland 21043
Telephone: (410) 988-9510

Private Practice:

St. Agnes Medical Center

3455 Wilkens Avenue, Suite 304

Baltimore, Maryland 21229

Telephone:(410) 644-1504

Fax:(410) 644-4157

Hospital Employment:

Medical Director (1968 to present)

The Paul Dudley White Coronary Care System

St. Agnes HealthCare

900 Caton Avenue

Baltimore, Maryland 21229-5299

Telephone:(410) 368-3200

Fax:(410) 368-3207

1962 Doctor of Medicine

University of Maryland

School of Medicine

Postdoctoral Training

1962-1963 Rotating Internship

1963-1966 Medical Resident - Oncology

1966-1967 Medical Resident

1967-1968 Executive Chief Medical Resident

Military Service

1963-1966 Clinical Association

National Cancer Institute

(1st year) Roswell Park Memorial Institute

Buffalo, NY

(2nd year) United States Public Health Service

(3rd year) Baltimore, Maryland

State Licensure

1962 Maryland

1957 Pharmacist

Hospital Affiliations

1968 - Present: Medical Director
The Paul Dudley White
Coronary Care System
St. Agnes Hospital
Baltimore, Maryland

1988 - Present Instructor in Medicine
Johns Hopkins University
School of Medicine

Professional Societies

Fellow, American College of Cardiology, 1995

Fellow, American College of Physicians, 1972

Board Certified in Internal Medicine, 1971

Member, Maryland Society of Cardiology

Member, Maryland Society of Internal Medicine

Past Chairperson, Emergency Cardiac Care Committee

Member, Med Chi Howard County Medical Society

Awards

1978 Founders' Award for Service

1982 Special Award for Outstanding Volunteer Service

1983 Special Award for Outstanding Volunteer Service
American Heart Association
Maryland Affiliate

1985 Department of Medicine Award

1994 25 Year Physician Award

1994 Heart Award

1994 Chest Pain Emergency Room Award

1995 The Lockard Conley Teaching Award

1996 Award Nominee

1996 The Dougherty Award

1986-1987 Johns Hopkins Hospital TPA Study

1990 ISIS 3 (International Study of Infarct Survival)

1991-1993 GUSTO I - Principal Investigator at St. Agnes Hospital

1994-1995 GUSTO II - Principal Investigator at St. Agnes Hospital
Ranked second place, USA, for number of patients enrolled.

1996-1997 GUSTO III - Principal Investigator at St. Agnes HealthCare

Presentations/Seminars

"Acute Prevention in Heart Attack: The Shifting Paradigm to Earlier Heart

1994 National Congress of Chest Pain Centers

1995 2nd National Congress of Chest Pain Centers
"Acute Myocardial Ischemia: Finding the Right Message"
with the Arizona Heart Institute
Phoenix, Arizona

1997 1st Maryland Chest Pain Center (E.D.) Research Conference

Accomplishments

1981Opened the first Chest Pain Emergency Room at St. Agnes Hospital, Baltimore, Maryland

1. Bahr RD. How one Baltimore hospital-St. Agnes-is handling the problem:the chest pain emergency room. Maryland State Med J 1979 28:9 82.

2. Bahr RD. Community apathy in regard to sudden death due to heart attack. Maryland State Med J 1979 28:9 74-75.

3. Bahr RD. A message to John Q. Public. Maryland State Med J 1979 28:9 76.

4. Bahr RD. State-of-the-art in community coronary care. Maryland State Med J 1983 32:7 516-520.

5. Bahr RD. Implantable intelligence or artificial heart. Hospital Practice 1983 18:2 17.

6. Bahr RD. The best way to contain an infarct is not to have one in the first place. Southern Med J 1984 77:1 65-68.

7. Bahr RD. Hospital efficiency in early coronary care. Maryland State Med

8. Bahr RD. Futuristic Medicine. (Letter) Maryland State Med J 1987 36:2

9. Guerci AD, Gerstenblith G, Brinker JA, Chandra NC, Gottlieb SO, Bahr

10. Bahr RD. Coronary Care: The next step. (Letter) The Lancet 1988 II:8624

11. Bahr RD. Early cardiac care centers. (Letter) Circulation 1989; 79:463

12.Chandra NC, Becker LC, Siu C, Petronis JD, Bahr RD, et al. TPA improves long term post MI LV function. (Abstract) 62nd Scientific Sessions. American Heart Association November, 1989.

13. Johns Hopkins University Investigators: Griffith LS, Reid PR, Platia EV, Ewart C, Becker D, Tabaznik B, Pollock S, Quartner J, Taylor D, Kelemam M, Gottlieb S, Mower M, Mirowski M, Chandra N, Bahr RD, et al. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction:The CAPS. Am J Cardiol 1990 39:5.

14.Mayur N, Ochaney M, Bahr RD. Thrombolysis in acute myocardial infarction:pre-TIMI II study of 255 patients followed for 1 to 5 years. (Abstract) Annual Sessions Final Scientific Program Guide, American College of Physicians. April 1990.

15. Shortall M, Kfoury A, Weiss R, Bahr RD. Thrombolytic therapy: the results of the first cooperative project between medical residents of three hospitals in Baltimore. (Abstract) Annual Session Final Scientific Program Guide, American College of Physicians, May 1990.

16.Gonzales A, Chwa E, Bahr RD. Acute mitral regurgitation-reversible cause of cardiogenic shock condition. (Abstract) 8th Annual Associates Meeting, Maryland Associates' Meeting of the American College of Physicians May, 1990.

17.Bahr RD. Let's teach patients about an obvious heart attack danger signal-chest pain. (Commentary) Am Med News June 1, 1990.

18. Balagtas R, Herrada J, Bahr RD. Thrombolytic therapy in MI:a retrospective study. Maryland Med J June 1990 39:6 561-564.

19.Bahr RD. Coronary care studies in a community hospital. (Abstract) Johns Hopkins University, School of Medicine, Department of Medicine Research Retreat, 1990.

20.Aufderheide TP, Bahr RD, Eisenberg MS, Krentz MJ. Thrombolytic therapy in the emergency department: accelerating time to treatment. Monograph. American College of Emergency Physicians 1990.

21. Kirshenbaum J, Flaherty J, Bahr RD et al. Coronary Thrombolysis with

22. Kirshenbaum J, Bahr RD, Flaherty JT, Gurewich V, Levine HJ, et al. Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. (Abstract) Am J Cardiol 1991 68: 1564-1569.

23.Bahr RD. Hughes Day revisited. (Letter) The Lancet 1990 336:311.

24. Bahr RD. Early cardiac care would reduce costs. (Letter) Am Med News Feb 11, 1991.

25.Bahr RD. Trial design in the thrombolytic age. (Letter) The Lancet 1991 337:8741 610-611.

26.Bahr RD. Chest pain emergency rooms: an idea whose time has come. (Editorial) J Cardiovascular Mgmt 1991 2:5 32-38.

27. Bahr RD. Access to early cardiac care: chest pain as a risk factor for heart attacks, and the emergence of early cardiac care centers. Maryland Med J 1992 41:2 133-137.

28.Chwa E, Gonzales A, Bahr RD et al. Papillary muscle rupture: A reversible cause of cardiogenic shock. Maryland Medical J 1992 41:10 893-897.

29. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3:a randomised comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41299 cases of suspected acute myocardial infarction. Lancet 1992 339:(8796) 780-781.

30.Bahr RD. Prodromal symptoms of a heart attack. (Letter) J Am CoIl Cardiol 1992 20:93 751-52.

31.Bahr Rd, Zeigler RG. Early cardiac care-the final risk factor. Pennsylvania J of Health, Physical Education, Recreation and Dance (HPERD) Fall, 1992 27-28.

32.Bahr RD. Emphasizing chest pain as a symptom of heart attack. (Letter) JAMA 1993 270:20 2435-36.

33.Bahr RD. Wiping out heart disease before the year 2000:an obtainable goal, a prediction for the future. J Cardiovascular Mgmt 1993 4:3 40-43.

34.Schulman SP, Goldschmidt-Clermont PJ, Navetta Fl, Chandra NC, Guerci AD, Califf RM, Ferguson JJ, Willerson JT, Wolfe CL, Bahr R, et al. Integrelin in unstable angina:a double-blind randomized trial. (Abstract presented at the 66th Scientific Sessions, American Heart Association) Circulation 1993 88:4:2 1-608 (No.3272).

35.The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. NEJM 1993 329:10 673-684.

36.Bahr RD. Reducing time to therapy in AMI patients:the new paradigm.(Editorial) Am J Emerg Med 1994 12:4 501-503.

37.Spiegler EJ, Civelek AC, Bahr RD et al. The use of technetium-99m sestamibi in the emergency room:can it assist in the triage of patients with chest pain. Clin Nucl Med 1993 18:807 Abstract.

38.Bahr RD. How pharmacists can help prevent heart attacks. Pharmacy Times 1994 60:11 33-38.

39.Bahr RD. The changing paradigm of acute heart attack prevention in the emergency department:a futuristic viewpoint? (Editorial) Ann Emerg Med 1995 25:1 95-96.

40.Bahr RD. The EHAC strategy:citizens chart the course for healthy people in the year 2000. J Cardiovascular Mgmt May/June 1995 6:3 19-25.

41.Bahr RD. The shifting paradigm to earlier heart attack care. Clinician Gardiner-CaIdwell SynerMed, Califon, NJ 1995 13:2 4-6.

42.Bahr RD. Growth of chest pain emergency departments throughout the United States:a cardiologist's spin on solving the heart attack problem. Coronary Artery Disease Oct 1995 6:10 827-830.

43.Graff L, Joseph T, Andelman R, Bahr RD, DeHart D, Espinosa J, Gibler B, Hoekstra J, Mathers-Dunbar L, Ornato JP, Page J, Severance H. Chest pain units in emergency departments-a report for the short term observation services section of the American College of Emergency Physicians. Am J Cardiol 1995 76:14 1036-39.

44.Bahr RD. Acute outpatient care and comprehensive management of acute myocardial ischemia in chest pain emergency departments. Maryland Medical J 1995 44:9 691-693.

45.Bahr Rd, Tonascia J. Measuring heart attack care performance: new indices and understanding. Am J Emergency Med Jam 1996 14:1 89-90.

46.Rus V, Bishara H, Bahr RD. Abstract. Kinetics of C5b-9 activation in patients with acute myocardial infarction treated with thrombolytics. Presented at American College of Physicians, Maryland Region 14th Annual Associates Meeting, May 9, 1996.

47.U KM, Mantadilok V, Fatterpaker AK, Bahr RD. Single (culprit) vessel disease in octogenarians with acute myocardial infarction and unstable angina. Maryland Med J June 1996 45:6 471-475.

48.Bahr RD. Concept of community chest pain centers in emergency departments. Clinician Aug 1996 14:4 5-6.

49.Schulman SP, Goldschmidt-Clermont PJ, Topol EJ, Califf RM, Navetta FI, Willerson JT, Chandra NS, Guerci AD, Ferguson JJ, Harrington RA, Lincoff AM, Yakubov SJ, Bray PF, Bahr RD, et al. Effects of integrelin, a platelet glycoprotein IIb-IIIa receptor antagonist, in unstable angina. A randomized multicenter trial. Circulation Nov 1996 94:9 2083-2089.

50.Serebruany VL, Shustov AR, Bahr RD, Topol EJ, Gurbel PA. Marked heterogeneity of platelet aggregation and major surface receptor expression in patients presenting with acute myocardial infarction, later enrolled in the GUSTO-III trial. Submitted to Circulation May 1997.

51.Gurbel PA, Serebruany VL, Shustov AR, Bahr RD, Carpo C, Topol EJ, for the GUSTO III investigators. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. The GUSTO III platelet study. Submitted to Circulation May 1997.

52.Bahr RD. Chest pain centers-real innovation or marketing hype? Cyberounds (The Univ of Texas) Jan 1997. www.cyberounds.com.

53.Gurbel PA, Serebruany VL, Shustov AR, Bahr RD, Ohman EM, Topol EJ. Increased baseline platelet P-selectin, and PECAM-1 as predictors of unsuccessful thrombolysis in patients with acute myocardial infarction. Submitted May 1997 to Amer J Cardiol.

54.Bahr RD. Heartfelt advice. Asian Hospital & Healthcare Management. 1997 2nd Edition.

Home | What's New | What is EHAC? | Abstracts & Articles
Reader's Digest | Contact Us | Search

Tips for Searching

www.ehac.org. Site by AllSoldOut Internet Solutions
Visit the Clinical Information EHAC site at www.chestpaincenters.org.
Copyright © 1996-2001 by St. Agnes Healthcare. All Rights Reserved.